Announcements

Cancers (ISSN: 2072-6694) will be attending ESMO 2022, held in Paris, France, from 9 to 13 September 2022. The European Society for Medical Oncology (ESMO) conference is the most important annual event with the greatest impact on cancer research, open to scholars and specialists from academia and the medical profession. During this conference, MDPI (at booth #P231) will welcome researchers from different backgrounds to visit and share their latest inspirations with us.

The following MDPI journals will be represented:

• Cancers (leading journal);
• Cells;
• Current Oncology;
• Biomedicines;
• Diagnostics;
• Future Pharmacology;
• IJMS;
• Onco;
• Pharmaceutics.

If you plan on attending this conference, feel free to stop by our booth #P231. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link: https://www.esmo.org/.

1. “Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study”
by Banys-Paluchowski, M.; Gasparri, M. L.; de Boniface, J.; Gentilini, O.; Stickeler, E.; Hartmann, S.; Thill, M.; Rubio, I. T.; Di Micco, R.; Bonci, E.-A.; et al.
Cancers 2021, 13(7), 1565; https://doi.org/10.3390/Cancers13071565
Available online: https://www.mdpi.com/2072-6694/13/7/1565 

2. “Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials”
by Rochigneux, P.; Chanez, B.; De Rauglaudre, B.; Mitry, E.; Chabannon, C.; Gilabert, M.
Cancers 2021, 13(2), 271; https://doi.org/10.3390/Cancers13020271
Available online: https://www.mdpi.com/2072-6694/13/2/271

3. “Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations”
by Lee, P. C.; Hendifar, A.; Osipov, A.; Cho, M.; Li, D.; Gong, J.
Cancers 2021, 13(7), 1706; https://doi.org/10.3390/Cancers13071706
Available online: https://www.mdpi.com/2072-6694/13/7/1706

4. “The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials”
by Hervieu, C.; Christou, N.; Battu, S.; Mathonnet, M.
Cancers 2021, 13(5), 1092; https://doi.org/10.3390/Cancers13051092
Available online: https://www.mdpi.com/2072-6694/13/5/1092

5. “N-3 Long-Chain Polyunsaturated Fatty Acids, Eicosapentaenoic and Docosahexaenoic Acid, and the Role of Supplementation during Cancer Treatment: A Scoping Review of Current Clinical Evidence”
by Newell, M.; Mazurak, V.; Postovit, L. M.; Field, C. J.
Cancers 2021, 13(6), 1206; https://doi.org/10.3390/Cancers13061206
Available online: https://www.mdpi.com/2072-6694/13/6/1206

6. “Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance”
by Wang, S.-H.; Yeh, S.-H.; Chen, P.-J.
Cancers 2021, 13(10), 2454; https://doi.org/10.3390/Cancers13102454
Available online: https://www.mdpi.com/2072-6694/13/10/2454

7. “The Effects of High-Intensity Interval Training vs. Moderate-Intensity Continuous Training on Inflammatory Markers, Body Composition, and Physical Fitness in Overweight/Obese Survivors of Breast Cancer: A Randomized Controlled Clinical Trial”
by Hooshmand Moghadam, B.; Golestani, F.; Bagheri, R.; Cheraghloo, N.; Eskandari, M.; Wong, A.; Nordvall, M.; Suzuki, K.; Pournemati, P.
Cancers 2021, 13(17), 4386; https://doi.org/10.3390/Cancers13174386
Available online: https://www.mdpi.com/2072-6694/13/17/4386

8. “Interstitial Photodynamic Therapy for Glioblastomas: A Standardized Procedure for Clinical Use”
by Leroy, H.-A.; Baert, G.; Guerin, L.; Delhem, N.; Mordon, S.; Reyns, N.
Cancers 2021, 13(22), 5754; https://doi.org/10.3390/Cancers13225754
Available online: https://www.mdpi.com/2072-6694/13/22/5754

9. “Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications”
by van Harten, A. M.; Brakenhoff, R. H.
Cancers 2021, 13(11), 2774; https://doi.org/10.3390/Cancers13112774
Available online: https://www.mdpi.com/2072-6694/13/11/2774

10. “Could Photodynamic Therapy Be a Promising Therapeutic Modality in Hepatocellular Carcinoma Patients? A Critical Review of Experimental and Clinical Studies”
by Kumar, A.; Moralès, O.; Mordon, S.; Delhem, N.
Cancers 2021, 13(20), 5176; https://doi.org/10.3390/Cancers13205176
Available online: https://www.mdpi.com/2072-6694/13/20/5176

1. “Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?”
by Victoria Heredia-Soto; Nuria Rodríguez-Salas; Jaime Feliu
Cancers 2021, 13(8), 1986; https://doi.org/10.3390/cancers13081986
Available online: https://www.mdpi.com/2072-6694/13/8/1986

2. “New Molecular Mechanisms and Clinical Impact of circRNAs in Human Cancer”
by Giulia Fontemaggi; Chiara Turco; Gabriella Esposito; Silvia Di Agostino
Cancers 2021, 13(13), 3154; https://doi.org/10.3390/cancers13133154
Available online: https://www.mdpi.com/2072-6694/13/13/3154

3. “Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer”
by Matthew G. Davey; Sean O. Hynes; Michael J. Kerin; Nicola Miller; Aoife J. Lowery
Cancers 2021, 13(17), 4455; https://doi.org/10.3390/cancers13174455
Available online: https://www.mdpi.com/2072-6694/13/17/4455

4. “Functional Interaction among lncRNA HOTAIR and MicroRNAs in Cancer and Other Human Diseases”
by Monica Cantile; Maurizio Di Bonito; Maura Tracey De Bellis; Gerardo Botti
Cancers 2021, 13(3), 570; https://doi.org/10.3390/cancers13030570
Available online: https://www.mdpi.com/2072-6694/13/3/570

5. “Resistance to Molecularly Targeted Therapies in Melanoma”
by Meet Patel; Adam Eckburg; Shahina Gantiwala; Zachary Hart; Joshua Dein; Katie Lam; Neelu Puri
Cancers 2021, 13(5), 1115; https://doi.org/10.3390/cancers13051115
Available online: https://www.mdpi.com/2072-6694/13/5/1115

6. “Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease”
by Gian Paolo Caviglia; Angelo Armandi; Chiara Rosso; Silvia Gaia; Serena Aneli; Emanuela Rolle; Maria Lorena Abate; Antonella Olivero; Aurora Nicolosi; Marta Guariglia; Davide Giuseppe Ribaldone; Patrizia Carucci; Giorgio Maria Saracco; Elisabetta Bugianesi
Cancers 2021, 13(10), 2305; https://doi.org/10.3390/cancers13102305
Available online: https://www.mdpi.com/2072-6694/13/10/2305

7. “Detection of Microsatellite Instability: State of the Art and Future Applications in Circulating Tumour DNA (ctDNA)”
by Pauline Gilson; Jean-Louis Merlin; Alexandre Harlé
Cancers 2021, 13(7), 1491; https://doi.org/10.3390/cancers13071491
Available online: https://www.mdpi.com/2072-6694/13/7/1491

8. “Urine as a Source of Liquid Biopsy for Cancer”
by Masanori Oshi; Vijayashree Murthy; Hideo Takahashi; Michelle Huyser; Maiko Okano; Yoshihisa Tokumaru; Omar M. Rashid; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Cancers 2021, 13(11), 2652; https://doi.org/10.3390/cancers13112652
Available online: https://www.mdpi.com/2072-6694/13/11/2652

9. “Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review”
by Greta Brezgyte; Vinay Shah; Daria Jach; Tatjana Crnogorac-Jurcevic
Cancers 2021, 13(11), 2722; https://doi.org/10.3390/cancers13112722
Available online: https://www.mdpi.com/2072-6694/13/11/2722

10. “Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies”
by Cora Palanca-Ballester; Aitor Rodriguez-Casanova; Susana Torres; Silvia Calabuig-Fariñas; Francisco Exposito; Diego Serrano; Esther Redin; Karmele Valencia; Eloisa Jantus-Lewintre; Angel Diaz-Lagares; Luis Montuenga; Juan Sandoval; Alfonso Calvo
Cancers 2021, 13(12), 3016; https://doi.org/10.3390/cancers13123016
Available online: https://www.mdpi.com/2072-6694/13/12/3016

Vaccines help the body fight disease and therefore immunization is a key component of primary health care and is a development success story that saves millions of lives every year. They work to protect the body from viruses (e.g., human papillomavirus, hepatitis B virus) or boost the body's immune system to fight cancer.

August is National Immunization Awareness Month, and we would like to share some of the high-quality and innovative research findings published in Cancers (ISSN: 2072-6694).

The list of relevant papers can be seen below:

“Plasma-Activated Medium Potentiates the Immunogenicity of Tumor Cell Lysates for Dendritic Cell-Based Cancer Vaccines”
by Tomić, S.; Petrović, A.; Puač, N.; Škoro, N.; Bekić, M.; Petrović, Z. L.; Čolić, M.
Cancers 2021, 13(7), 1626; https://doi.org/10.3390/cancers13071626
Available online: https://www.mdpi.com/2072-6694/13/7/1626

“COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience”
by So, A. C. P.; McGrath, H.; Ting, J.; Srikandarajah, K.; Germanou, S.; Moss, C.; Russell, B.; Monroy-Iglesias, M.; Dolly, S.; Irshad, S.; Van Hemelrijck, M.; Enting, D.
Cancers 2021, 13(14), 3573; https://doi.org/10.3390/cancers13143573
Available online: https://www.mdpi.com/2072-6694/13/14/3573

“Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs”
by Agbarya, A.; Sarel, I.; Ziv-Baran, T.; Agranat, S.; Schwartz, O.; Shai, A.; Nordheimer, S.; Fenig, S.; Shechtman, Y.; Kozlener, E.; Taha, T.; Nasrallah, H.; Parikh, R.; Elkoshi, N.; Levy, C.; Khoury, R.; Brenner, R.
Cancers 2021, 13(16), 4191; https://doi.org/10.3390/cancers13164191
Available online: https://www.mdpi.com/2072-6694/13/16/4191

“Vaccine Increases the Diversity and Activation of Intratumoral T Cells in the Context of Combination Immunotherapy”
by Horn, L. A.; Fousek, K.; Hamilton, D. H.; Hodge, J. W.; Zebala, J. A.; Maeda, D. Y.; Schlom, J.; Palena, C.
Cancers 2021, 13(5), 968; https://doi.org/10.3390/cancers13050968
Available online: https://www.mdpi.com/2072-6694/13/5/968

“Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment”
by Ghandili, S.; Schönlein, M.; Lütgehetmann, M.; Schulze zur Wiesch, J.; Becher, H.; Bokemeyer, C.; Sinn, M.; Weisel, K. C.; Leypoldt, L. B.
Cancers 2021, 13(15), 3800; https://doi.org/10.3390/cancers13153800
Available online: https://www.mdpi.com/2072-6694/13/15/3800

“Antigenic Essence: Upgrade of Cellular Cancer Vaccines”
by Lokhov, P. G.; Balashova, E. E.
Cancers 2021, 13(4), 774; https://doi.org/10.3390/cancers13040774
Available online: https://www.mdpi.com/2072-6694/13/4/774

“Vaccine-Based Immunotherapy for Head and Neck Cancers”
by Beyaert, S.; Machiels, J. -P.; Schmitz, S.
Cancers 2021, 13(23), 6041; https://doi.org/10.3390/cancers13236041
Available online: https://www.mdpi.com/2072-6694/13/23/6041

“Functional T Cell Reactivity to Melanocyte Antigens Is Lost during the Progression of Malignant Melanoma, but Is Restored by Immunization”
by Przybyla, A.; Lehmann, A. A.; Zhang, T.; Mackiewicz, J.; Galus, Ł.; Kirchenbaum, G. A.; Mackiewicz, A.; Lehmann, P. V.
Cancers 2021, 13(2), 223; https://doi.org/10.3390/cancers13020223
Available online: https://www.mdpi.com/2072-6694/13/2/223

“Vaccination against PD-L1 with IO103 a Novel Immune Modulatory Vaccine in Basal Cell Carcinoma: A Phase IIa Study”
by Jørgensen, N. G.; Kaae, J.; Grauslund, J. H.; Met, Ö.; Nielsen, S. L.; Pedersen, A. W.; Svane, I. M.; Ehrnrooth, E.; Andersen, M. H.; Zachariae, C.; Skov, L.
Cancers 2021, 13(4), 911; https://doi.org/10.3390/cancers13040911
Available online: https://www.mdpi.com/2072-6694/13/4/911

“Novel Protein-Based Vaccine against Self-Antigen Reduces the Formation of Sporadic Colon Adenomas in Mice”
by Belnoue, E.; Leystra, A. A.; Carboni, S.; Cooper, H. S.; Macedo, R. T.; Harvey, K. N.; Colby, K. B.; Campbell, K. S.; Vanderveer, L. A.; Clapper, M. L.; Derouazi, M.
Cancers 2021, 13(4), 845; https://doi.org/10.3390/cancers13040845
Available online: https://www.mdpi.com/2072-6694/13/4/845

You are welcome to submit relevant papers to the journal Section “Cancer Immunology and Immunotherapy” at https://www.mdpi.com/journal/cancers/sections/Cancer_Immunology_Immunotherapy.

Dr. Subbaya Subramanian
Associate Section Editor-in-Chief of Cancers

Sarcomas are malignant tumors that commonly arise from bone and soft tissue such as muscle, fat, and nerves. Bone sarcomas include osteosarcoma, chondrosarcoma, and Ewing’s sarcoma, and soft-tissue sarcomas include liposarcoma, undifferentiated pleomorphic sarcoma, myxofibrosarcoma, synovial sarcoma, leiomyosarcoma, and rhabdomyosarcoma. The characteristics of sarcoma are its rarity (low frequency of occurrence) and diversity (various histological types). The frequency of sarcoma is extremely low compared to carcinomas such as lung cancer and colon cancer, and sarcomas account for only 1% of all malignant tumors.

Due to the rarity and variety of sarcoma, it is difficult to diagnose and treat the disease appropriately. In addition, many patients are referred to cancer centers after receiving unplanned excision.

July has been designated as “Sarcoma Awareness Month”, with the yellow ribbon as a symbol, and various activities have been carried out so far to raise awareness of this rare cancer for research support and development in treatment all over the world.

We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to highlight multiple research projects in this field, covering mechanisms in the tumor microenvironment, early detection, promising therapeutic targets, and new therapeutic strategies. We hope this announcement will provide useful information for clinical practice.

The list of relevant papers can be seen below:

• “Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment?”
  by Anne Gomez-Brouchet et al.
  Available online: https://www.mdpi.com/2072-6694/13/3/423

• “Exploring Metabolic Adaptations to the Acidic Microenvironment of Osteosarcoma Cells Unveils Sphingosine 1-Phosphate as a Valuable Therapeutic Target”
  by Margherita Cortini et al.
  Available online: https://www.mdpi.com/2072-6694/13/2/311

• “Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies”
  by Claudia Maria Hattinger et al.
  Available online: https://www.mdpi.com/2072-6694/13/12/2878

• “Chondrosarcoma-from Molecular Pathology to Novel Therapies”
  by Agnieszka E. Zając et al.
  Available online: https://www.mdpi.com/2072-6694/13/10/2390

• “Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy”
  by Luana Madalena Sousa et al.
  Available online: https://www.mdpi.com/2072-6694/13/15/3885

You are welcome to submit relevant papers to the Special Issue “Sarcoma and Bone Cancer Awareness Month” at https://www.mdpi.com/si/cancers/IQ9P79398L.

Dr. Shinji Miwa, Editorial Board Member of Cancers

The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.

* Journals given their first Impact Factor in 2022

Source: 2021 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2022)

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2021 in the “Medicine & Pharmacology” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

• Jasper Fuk-Woo Chan, Queen Mary Hospital, Hong Kong
• Mateusz Maciejczyk, Medical University of Bialystok, Poland

Current Oncology:

• Matteo Lambertini, University of Genova, Italy

Dentistry Journal:

• Helen Rogers, Newcastle University, UK

Healthcare:

• Amir Karami, University of South Carolina, USA

Journal of Clinical Medicine:

• Andrea Palermo, Campus Bio-Medico University, Italy

Journal of Personalized Medicine:

• Simone Di Franco, University of Palermo, Italy
• Catriona Hippman, University of Calgary, Canada

Medicina:

• Veeru Kasivisvanathan, University College London, UK
• Andrea Cortegiani, University of Palermo, Italy; University Hospital Policlinico Paolo Giaccone, Italy

Pharmaceutics:

• Qi Zhou, Purdue University, USA

We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Medicine & Pharmacology” category for their outstanding presentations and to present them with the prize.

MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the Travel Awards winners for the year 2021 and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Biomedicines:

• Soheil Saeedi, University of Zurich, Switzerland

Dentistry Journal:

• Shawn Alexander Hallett, University of Michigan, USA

Medicines:

• Claire Albert, Yale University, USA

Pharmaceuticals:

• Raquel Filipa da Costa Viveiros, NOVA University of Lisbon, Portugal
• Patrick Jim Küppers, University Hospital Bonn, Germany

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers, and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize winners for the year 2021 in the “Medicine & Pharmacology” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievement. MDPI will continue to provide support and recognition to the academic community.

Cancers:

• Antonio G. Solimando, University of Bari Aldo Moro, Italy
• Chenghui Li, University of Arkansas for Medical Sciences, USA
• Joaquim Carreras, Tokai University, Japan
• Pierfrancesco Franco, University of Turin School of Medicine, Italy
• Laurentiu Pop, University of Texas Southwestern Medical Center, USA

Current Oncology:

• Margaret Fitch, University of Toronto, Canada
• Caroline Mariano, BC Cancer Agency, Canada; University of British Columbia, Canada

Healthcare:

• Naser Alsharairi, Griffith University, Australia
• Peter W. Choate, Mount Royal University, Canada
• Qin Xiang Ng, National University of Singapore, Singapore

Journal of Clinical Medicine:

• Giulio Francesco, Sapienza University of Rome, Italy
• Sebastian Schnaubelt, Medical University of Vienna, Austria
• Olga Kislitsina, Northwestern University, Northwestern Memorial Hospital, USA

Journal of Personalized Medicine:

• Onofrio Laselva, University of Foggia, Italy
• Ping-Hsun Wu, Kaohsiung Medical University, Taiwan
• Vladimir Vladimirov, Virginia Commonwealth University, USA
• Mauro Giuffrè, University of Trieste, Italy

Medical Sciences:

• Erika Palmieri, National Cancer Institute at Frederick, USA

Tomography:

• Anjul Khadria, California Institute of Technology, Pasadena, USA

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.

We are honored to present the winners in the “Medicine & Pharmacology” category, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.

MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

• “Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials”

by Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm

Antibiotics 2019, 8(2), 55; doi:10.3390/antibiotics8020055

• “Antibiotic Discovery: Where Have We Come from, Where Do We Go?”

by Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado

Antibiotics 2019, 8(2), 45; doi:10.3390/antibiotics8020045

Dentistry Journal:

• “Regeneration of the Periodontal Apparatus in Aggressive Periodontitis Patients”

by Zvi Artzi, Shiran Sudri, Ori Platner and Avital Kozlovsky

Dent. J. 2019, 7(1), 29; doi:10.3390/dj7010029

• “Treatment of Peri-Implant Mucositis with Repeated Application of Chlorhexidine Chips or Gel during Supportive Therapy—A Randomized Clinical Trial”

by Philipp Sahrmann, Cyrill Bettschart, Daniel B. Wiedemeier, Ahmed Al-Majid, Thomas Attin and Patrick R. Schmidlin

Dent. J. 2019, 7(4), 115; doi:10.3390/dj7040115

Healthcare:

• “Two-Year Use of Care Robot Zora in Dutch Nursing Homes: An Evaluation Study”

by Chantal Huisman and Helianthe Kort

Healthcare 2019, 7(1), 31; doi:10.3390/healthcare7010031

• “The Interlinked Rising Epidemic of Insufficient Sleep and Diabetes Mellitus”

by Vijay Kumar Chattu, Soosanna Kumary Chattu, Deepa Burman, David Warren Spence and Seithikurippu R. Pandi-Perumal

Healthcare 2019, 7(1), 37; doi:10.3390/healthcare7010037

Journal of Clinical Medicine:

• “Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues”

by Eija Könönen, Mervi Gursoy and Ulvi Kahraman Gursoy

Clin. Med. 2019, 8(8), 1135; doi:10.3390/jcm8081135

• “The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity”

by Yueyuan Zhou, Yusuke Yamamoto, Zhongdang Xiao and Takahiro Ochiya

Clin. Med. 2019, 8(7), 1025; doi:10.3390/jcm8071025

• “Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR”

by Tara K. Sigdel, Felipe Acosta Archila, Tudor Constantin, Sarah A. Prins, Juliane Liberto, Izabella Damm, Parhom Towfighi, Samantha Navarro, Eser Kirkizlar, Zachary P. Demko, Allison Ryan, Styrmir Sigurjonsson, Reuben D. Sarwal, Szu-Chuan Hseish, Chitranon Chan-On, Bernhard Zimmermann, Paul R. Billings, Solomon Moshkevich and Minnie M. Sarwal

Clin. Med. 2019, 8(1), 19; doi:10.3390/jcm8010019

Medicina:

• “Tumor Microenvironment”

by Borros Arneth

Medicina 2020, 56(1), 15; doi: 10.3390/medicina56010015

• “Comparative Epidemiology and Resistance Trends of Common Urinary Pathogens in a Tertiary-Care Hospital: A 10-Year Surveillance Study”

by Márió Gajdács, Marianna Ábrók, Andrea Lázár, and Katalin Burián

Medicina 2019, 55(7), 356; doi: 10.3390/medicina55070356

Pharmaceutics:

• “3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology”

by Atheer Awad, Fabrizio Fina, Sarah J. Trenfield, Pavanesh Patel, Alvaro Goyanes, Simon Gaisford and Abdul W. Basit.

Pharmaceutics 2019, 11(4), 148; doi:10.3390/pharmaceutics11040148

• “Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems”

by Constantin Mircioiu, Victor Voicu, Valentina Anuta, Andra Tudose, Christian Celia, Donatella Paolino, Massimo Fresta, Roxana Sandulovici and Ion Mircioiu

Pharmaceutics 2019, 11(3), 140; doi:10.3390/pharmaceutics11030140